Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved a randomized clinical trial

JAMA Internal Medicine

Volumn 173, Issue 18, 2013, Pages 1725-1732

  Gupta, Samir ^a,b   Halm, Ethan A ^c,d,e   Rockey, Don C ^f   Hammons, Marcia ^g   Koch, Mark ^h   Carter, Elizabeth ^h   Valdez, Luisa ^g   Tong, Liyue ^c   Ahn, Chul ^c,d   Kashner, Michael ^d,i,j   Argenbright, Keith ^c,d,g   Tiro, Jasmin ^c,d   Geng, Zhuo ^c,e   Pruitt, Sandi ^c,d   Skinner, Celette Sugg ^c,d  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h John Peter Smith Health Network   (United States)

ⁱ LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j DEPARTMENT OF VETERANS AFFAIRS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CAUCASIAN; COLONOSCOPY; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HISPANIC; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEGRO; OCCULT BLOOD TEST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84885833634     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.9294     Document Type: Article

References (34)

1. US Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
2. Levin B, Lieberman DA, McFarland B, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570-1595.
3. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-573.
4. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1611-1621.
5. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(9):659-669.
6. Graser A, Stieber P, Nagel D, et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut. 2009;58(2):241-248.
7. Walsh JM, Terdiman JP. Colorectal cancer screening: clinical applications. JAMA. 2003;289(10):1297-1302.
8. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582.
9. Gupta S. Will test-specific adherence predict the best colorectal cancer screening strategy? Ann Intern Med. 2009;150(5):359-360.
10. Inadomi JM. Taishotoyama Symposium: barriers to colorectal cancer screening: economics, capacity and adherence. J Gastroenterol Hepatol. 2008;23(Suppl 2):S198-S204.
11. Lewin ME, Altman S; Committee on the Changing Market, Managed Care, and the Future Viability of Safety Net Providers. America's Health Care Safety Net: Intact but Endangered. Washington, DC: National Academy Press; 2000.
12. Lewin ME, Baxter RJ. America's health care safety net: revisiting the 2000 IOM report. Health Aff (Millwood). 2007;26(5):1490-1494.
13. Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101-110.
14. Green AR, Peters-Lewis A, Percac-Lima S, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med. 2008;23(6): 834-840.
15. Jo AM, Maxwell AE, Wong WK, Bastani R. Colorectal cancer screening among underserved Korean Americans in Los Angeles County. http://link.springer.com/ article/10.1007/s10903-007-9066-6. Accessed July 3, 2013.
16. Levy BT, Nordin T, Sinift S, Rosenbaum M, James PA. Why hasn't this patient been screened for colon cancer? an Iowa Research Network study. J Am Board Fam Med. 2007;20(5):458-468.
17. Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93(4): 635-641.
18. Steinwachs D, Allen JD, Barlow WE, et al. NIH state-of-the-science conference statement: enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements. 2010;27(1):1-31.
19. Levy BT, Daly JM, Xu Y, Ely JW. Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices. J Am Board Fam Med. 2012;25(1):73-82.
20. Daly JM, Levy BT, Merchant ML, Wilbur J. Mailed fecal-immunochemical test for colon cancer screening. J Community Health. 2010;35(3): 235-239.
21. Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004;96(10):770-780.
22. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083-2091.
23. Jean-Jacques M, Kaleba EO, Gatta JL, Gracia G, Ryan ER, Choucair BN. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial. Ann Fam Med. 2012;10(5):412-417.
24. Coronado GD, Golovaty I, Longton G, Levy L, Jimenez R. Effectiveness of a clinic-based colorectal cancer screening promotion program for underserved Hispanics. Cancer. 2011;117(8):1745-1754.
25. Walsh JM, Salazar R, Nguyen TT, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1-14.
26. Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906-912.
27. Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211-217
28. Quintero E, Castells A, Bujanda L, et al; COLONPREV Study Investigators. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366(8):697-706.
29. Segnan N, Senore C, Andreoni B, et al; SCORE3 Working Group-Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology. 2007;132(7):2304-2312
30. Multicentre Australian Colorectal-neoplasia Screening (MACS) Group. A comparison of colorectal neoplasia screening tests: a multicentre community-based study of the impact of consumer choice. MedJAust. 2006;184(11):546-550.
31. Sharaf RN, Ladabaum U. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol. 2013;108(1):120-132.
32. HR 3590: Patient Protection and Affordable Care Act, 2009. http://thomas.loc.gov/cgi-bin/query/z?c111:H.R.3590. Accessed April 27, 2010, 2010.
33. Cassidy A. Health policy brief: preventive services without cost sharing. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief-id=37. Accessed July 3, 2013.
34. Kempe KL, Shetterly SM, France EK, Levin TR. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012;18(7):370-378.